Alternative Anastrozole Target CYP4V2 Impairs Neurons in Preclinical Models of Inherited Tauopathy
Chiara Pedicone, Sarah A. Weitzman, Joshua Orrick…·Masahiro Sonoshita
This study identifies anastrozole's off-target CYP4V2 as a neuroprotective factor in tauopathy models by reducing Tau phosphorylation and oxidative stress.